课题基金 / 基金详情

Basic studies for telomerase as a novel target for cancer diganosis and therapy

Basic studies for telomerase as a novel target for cancer diganosis and therapy
端粒酶作为癌症诊断和治疗新靶点的基础研究
批准号:
08457303
负责人:
HIYAMA Eiso
金额:
$3.71万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 --

项目摘要

项目成果

HIYAMA Eiso的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Telomere length and telomerase activity were measured in 130 breast cancers, 70 gastric cancers, 94 colonic cancers and 43 pancreatic cancers. Telomere (terminal restriction fragments) lengths of these tumor specimens were measured by Southern blot analysis. Reduced and elongated telomere lengths were detected in 27% and 8%, respectively. Telomerase activity was measured using Telomeric Repeat Amplification Protocol (TRAP) assay. Among noncancerous tissues, telomerase activity was detectable in gastric and colonic mucosal specimens. TRAP assay for serial sections from the surface of these specimens revealed telomerase activity was detectable in the portions where intestinal crypt cells (intestinal stem cells) exist. Among cancer tissues, telomerase activation or upregulation was detected in 95% of breast cancres, 85% of gastric cancers, 73% of colonic cancers, 96% of pancreatic cancers. Non-isotopic TRAP assay using of 35 PCR cycles and densitographic analysis showed the same sensitivi … More ty as usual TRAP assay, indicating the non-isotopic TRAP assay is useful for clinical examination. TRAP assay using of in situ PCR was tried to measure in cryosections. In peritoneal disseminated cells and pancreatic brushing cells of cancer, telomerase expressing cells and non-expressing cells coexisted and telomerase expression was likely to be correlated with cell cycles. In 82 samples of fine needle aspirated cells of breast tumors and 38 smear samples obtained by gastric or colonic endoscopy, 83% of the samples diagnosed as malignancy showed detectable telomerase activity. Thus, telomerase activity was useful for the diagnosis of cancer cell existence. However, telomerase activation or upregulation does not always exist in all cancer cells but is likely to be acquired according to cancer progression. Thus, anticancer therapy using of inhibitors of telomerase is considered to be useful for advanced cancers. However, canful attentions are required for the side effects of normal mucosal and hematopoietic stem cells. Less
期刊论文(40)
专著(0)
科研奖励(0)
会议论文
桧山英三: "固形癌とテロメラーゼ." Surgery Frontier. 4. 29-36 (1997)
Eizo Hiyama:“实体瘤和端粒酶。” 4. 29-36 (1997)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Eiso Hiyama: "Telomerase activity in human breast tumors" Journal of the National Cancer Institute. 88. 116-122 (1996)
Eiso Hiyama:“人类乳腺肿瘤中的端粒酶活性”国家癌症研究所杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
40
    Analysis of genomic aberrations, risk of secondary cancer development and, hereditary effects by irradiation and chemotherapy in children
    • 批准号:
      26670764
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2014
    • 负责人:
      HIYAMA Eiso
    • 依托单位:
    Genomic aberrations by chemoradiotherapy in children and its transfer to next generation
    • 批准号:
      25670743
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2013
    • 负责人:
      HIYAMA Eiso
    • 依托单位:
    Detection of molecular targets for childhood cancers using genomics and cellomics: targeting for cancer stem cells
    • 批准号:
      24249084
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $28.37万
    • 财政年份:
      2012
    • 负责人:
      HIYAMA Eiso
    • 依托单位:
    Survey of childhood liver tumors in Asian area and infrastructural development of international collaboration study by Japanese study group for pediatric liver tumors (JPLT)
    • 批准号:
      23256006
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $27.29万
    • 财政年份:
      2011
    • 负责人:
      HIYAMA Eiso
    • 依托单位:
    海外基金